CLECL1P
Putative C-type lectin-like domain family 1
Also known as: CLCL1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for CLECL1P in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
167 residues, UniProt reviewed canonical sequence.
>Q8IZS7|CLECL1P
1 MVSNFFHVIQ VFEKSATLIS KTEHIGFVIY SWRKSTTHLG SRRKFAISIY LSEVSLQKYD
61 CPFSGTSFVV FSLFLICAMA GDVVYADIKT VRTSPLELAF PLQRSVSFNF STVHKSCPAK
121 DWKVHKGKCY WIAETKKSWN KSQNDCAINN SYLMVIQDIT AMVRFNILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLECL1P can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.49
OntologyGO
Biological processes
- B cell adhesion
- positive regulation of interleukin-4 production
- positive regulation of T cell proliferation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLECL1P as an antibody target. Whether an autoantibody or antibody against CLECL1P could matter depends on whether native CLECL1P is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLECL1P is annotated at the cell surface, where native CLECL1P is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLECL1P as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...